Sulindak

Sulindak
Klinički podaci
AHFS/Drugs.com	Monografija
Identifikatori
CAS broj	38194-50-2
ATC kod	M01AB02
PubChem	1548887
DrugBank	DB00605
ChemSpider	1265915
KEGG	C01531
ChEBI	CHEBI:9352
ChEMBL	CHEMBL15770
Hemijski podaci
Formula	C20H17FO3S
Mol. masa	356,411
SMILES	eMolekuli & PubHem
InChI
	InChI=1S/C20H17FO3S/c1-12-17(9-13-3-6-15(7-4-13)25(2)24)16-8-5-14(21)10-19(16)18(12)11-20(22)23/h3-10H,11H2,1-2H3,(H,22,23)/b17-9-; Key: MLKXDPUZXIRXEP-MFOYZWKCSA-N
Fizički podaci
Tačka topljenja	183 °C (361 °F)
Farmakokinetički podaci
Poluvreme eliminacije	7,8 h
Farmakoinformacioni podaci
Trudnoća	?
Pravni status
Način primene	Oralno

Sulindak je organsko jedinjenje, koje sadrži 20 atoma ugljenika i ima molekulsku masu od 356,411 Da.^[6]^[7]

Osobine

Osobina	Vrednost
Broj akceptora vodonika	3
Broj donora vodonika	1
Broj rotacionih veza	4
Particioni koeficijent^[8] (ALogP)	3,6
Rastvorljivost^[9] (logS, log(mol/L))	-5,9
Polarna površina^[10] (PSA, Å²)	73,6

Reference

↑ Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today 15 (23-24): 1052-7. DOI:10.1016/j.drudis.2010.10.003. PMID 20970519. edit
↑ Evan E. Bolton, Yanli Wang, Paul A. Thiessen, Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”. Annual Reports in Computational Chemistry 4: 217-241. DOI:10.1016/S1574-1400(08)00012-1.
↑ Hettne KM, Williams AJ, van Mulligen EM, Kleinjans J, Tkachenko V, Kors JA. (2010). „Automatic vs. manual curation of a multi-source chemical dictionary: the impact on text mining”. J Cheminform 2 (1): 3. DOI:10.1186/1758-2946-2-3. PMID 20331846. edit
↑ Joanne Wixon, Douglas Kell (2000). „Website Review: The Kyoto Encyclopedia of Genes and Genomes — KEGG”. Yeast 17 (1): 48–55. DOI:10.1002/(SICI)1097-0061(200004)17:1<48::AID-YEA2>3.0.CO;2-H.
↑ Gaulton A, Bellis LJ, Bento AP, Chambers J, Davies M, Hersey A, Light Y, McGlinchey S, Michalovich D, Al-Lazikani B, Overington JP. (2012). „ChEMBL: a large-scale bioactivity database for drug discovery”. Nucleic Acids Res 40 (Database issue): D1100-7. DOI:10.1093/nar/gkr777. PMID 21948594. edit
↑ Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS (2011). „DrugBank 3.0: a comprehensive resource for omics research on drugs”. Nucleic Acids Res. 39 (Database issue): D1035-41. DOI:10.1093/nar/gkq1126. PMC 3013709. PMID 21059682. edit
↑ David S. Wishart, Craig Knox, An Chi Guo, Dean Cheng, Savita Shrivastava, Dan Tzur, Bijaya Gautam, and Murtaza Hassanali (2008). „DrugBank: a knowledgebase for drugs, drug actions and drug targets”. Nucleic Acids Res 36 (Database issue): D901-6. DOI:10.1093/nar/gkm958. PMC 2238889. PMID 18048412. edit
↑ Ghose, A.K., Viswanadhan V.N., and Wendoloski, J.J. (1998). „Prediction of Hydrophobic (Lipophilic) Properties of Small Organic Molecules Using Fragment Methods: An Analysis of AlogP and CLogP Methods”. J. Phys. Chem. A 102: 3762-3772. DOI:10.1021/jp980230o.
↑ Tetko IV, Tanchuk VY, Kasheva TN, Villa AE. (2001). „Estimation of Aqueous Solubility of Chemical Compounds Using E-State Indices”. Chem Inf. Comput. Sci. 41: 1488-1493. DOI:10.1021/ci000392t. PMID 11749573. edit
↑ Ertl P., Rohde B., Selzer P. (2000). „Fast calculation of molecular polar surface area as a sum of fragment based contributions and its application to the prediction of drug transport properties”. J. Med. Chem. 43: 3714-3717. DOI:10.1021/jm000942e. PMID 11020286. edit

Literatura

Hardman JG, Limbird LE, Gilman AG. (2001). Goodman & Gilman's The Pharmacological Basis of Therapeutics (10 izd.). New York: McGraw-Hill. DOI:10.1036/0071422803. ISBN 0-07-135469-7.
Thomas L. Lemke, David A. Williams, ur. (2007). Foye's Principles of Medicinal Chemistry (6 izd.). Baltimore: Lippincott Willams & Wilkins. ISBN 0-7817-6879-9.

Spoljašnje veze

	Portal Medicina
	Portal Hemija

Sulindac

[1] Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today 15 (23-24): 1052-7. DOI:10.1016/j.drudis.2010.10.003. PMID 20970519. edit

[2] Evan E. Bolton, Yanli Wang, Paul A. Thiessen, Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”. Annual Reports in Computational Chemistry 4: 217-241. DOI:10.1016/S1574-1400(08)00012-1.

[3] Hettne KM, Williams AJ, van Mulligen EM, Kleinjans J, Tkachenko V, Kors JA. (2010). „Automatic vs. manual curation of a multi-source chemical dictionary: the impact on text mining”. J Cheminform 2 (1): 3. DOI:10.1186/1758-2946-2-3. PMID 20331846. edit

[4] Joanne Wixon, Douglas Kell (2000). „Website Review: The Kyoto Encyclopedia of Genes and Genomes — KEGG”. Yeast 17 (1): 48–55. DOI:10.1002/(SICI)1097-0061(200004)17:1<48::AID-YEA2>3.0.CO;2-H.

[5] Gaulton A, Bellis LJ, Bento AP, Chambers J, Davies M, Hersey A, Light Y, McGlinchey S, Michalovich D, Al-Lazikani B, Overington JP. (2012). „ChEMBL: a large-scale bioactivity database for drug discovery”. Nucleic Acids Res 40 (Database issue): D1100-7. DOI:10.1093/nar/gkr777. PMID 21948594. edit

[6] Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS (2011). „DrugBank 3.0: a comprehensive resource for omics research on drugs”. Nucleic Acids Res. 39 (Database issue): D1035-41. DOI:10.1093/nar/gkq1126. PMC 3013709. PMID 21059682. edit

[7] David S. Wishart, Craig Knox, An Chi Guo, Dean Cheng, Savita Shrivastava, Dan Tzur, Bijaya Gautam, and Murtaza Hassanali (2008). „DrugBank: a knowledgebase for drugs, drug actions and drug targets”. Nucleic Acids Res 36 (Database issue): D901-6. DOI:10.1093/nar/gkm958. PMC 2238889. PMID 18048412. edit

[8] Ghose, A.K., Viswanadhan V.N., and Wendoloski, J.J. (1998). „Prediction of Hydrophobic (Lipophilic) Properties of Small Organic Molecules Using Fragment Methods: An Analysis of AlogP and CLogP Methods”. J. Phys. Chem. A 102: 3762-3772. DOI:10.1021/jp980230o.

[9] Tetko IV, Tanchuk VY, Kasheva TN, Villa AE. (2001). „Estimation of Aqueous Solubility of Chemical Compounds Using E-State Indices”. Chem Inf. Comput. Sci. 41: 1488-1493. DOI:10.1021/ci000392t. PMID 11749573. edit

[10] Ertl P., Rohde B., Selzer P. (2000). „Fast calculation of molecular polar surface area as a sum of fragment based contributions and its application to the prediction of drug transport properties”. J. Med. Chem. 43: 3714-3717. DOI:10.1021/jm000942e. PMID 11020286. edit

[1]

[2]

[3]

[4]

[5]

[6]

[7]

[8]

[9]

[10]

p r u Nesteroidni antiinflamatorni lek (NSAIL) (M01A i M02A, N02BA)
Salicilati	Aspirin (acetilsalicilna kiselina) • Aloksiprin • Benorilat • Diflunisal • Etenzamid • Magnezijum salicilat • Metil salicilat • Salsalat • Salicin • Salicilamid • Natrijum salicilat
Arilalkanoinske kiseline	Diklofenak • Aceklofenak • Acemetacin • Alklofenak • Bromfenak • Etodolak • Indometacin • Indometacin farnesil • Nabumeton • Oksametacin • Proglumetacin • Sulindac • Tolmetin
2-Arilpropionske kiseline (profeni)	Ibuprofen • Alminoprofen • Benoksaprofen • Karprofen • Deksibuprofen • Deksketoprofen • Fenbufen • Fenoprofen • Flunoksaprofen • Flurbiprofen • Ibuproksam • Indoprofen^† • Ketoprofen • Ketorolak • Loksoprofen • Miroprofen • Naproksen • Oksaprozin • Pirprofen • Suprofen • Tarenflurbil • Tiaprofenska kiselina
N-Arilantranilne kiseline (fenaminske kiseline)	Mefenamska kiselina • Flufenaminska kiselina • Meklofenaminska kiselina • Tolfenaminska kiselina
Pirazolidinski derivativi	Fenilbutazon • Ampiron • Azapropazon • Klofezon • Kebuzon • Metamizol • Mofebutazon • Oksifenbutazon • Fenazon • Sulfinpirazon
Oksikami	Piroksikam • Droksikam • Lornoksikam • Meloksikam • Tenoksikam • Ampiroksikam
COX -2 inhibitori	Celekoksib • Derakoksib^‡ • Etorikoksib • Firokoksib^‡ • Lumirakoksib^† • Parekoksib • Rofekoksib^† • Valdekoksib^†
Sulfonanilidi	Nimesulid
Proizvodi sa topičkom primenom	Bendazac • Diklofenak • Etofenamat • Felbinak • Flurbiprofen • Ibuprofen • Indometacin • Ketoprofen • Naproksen • Piroksikam • Suprofen
COX-inhibirajući donori azot oksida	Naprokscinod
Drugi	Fluprohazon
Podebljani nazivi označavaju jedinjenja (spojeve) inicijalno razvijene u specifičnim grupama. ^†Lekovi povučeni sa tržišta. ^‡Veterinarski lekovi.